Saad Kubba
- Assistant Clinical Professor, Medicine - (Clinical Series Track)
- (520) 626-6453
- Sarver Heart Center, Rm. 2301
- skubba@arizona.edu
Biography
Dr. Kubba is part of the Advanced Heart Disease and Transplant Cardiology team, Pulmonary Vascular and Pulmonary Hypertension Program, and provides general cardiology care as well as treating patients with complex heart conditions.
He utilizes both invasive and non-invasive study modalities in evaluating patients with complex heart disease and hemodynamics. His expertise includes valvular heart disease, exercise physiology, vascular medicine, advanced heart failure (both preserved and reduced ejection fraction), ventricular assist devices, transplant cardiology, right heart failure and pulmonary hypertension. Dr. Kubba utilizes a multidisciplinary approach in managing cardiomyopathies including cardiac sarcoidosis, cardiac amyloidosis, hypertrophic, non-compaction, restrictive and dilated cardiomyopathy.
His board certifications include National Board of Echocardiography, Certification Board of Nuclear Cardiology, Certification Board of Cardiovascular Computed Tomography, Registered Physician Vascular Interpreter, American Board of Internal Medicine in Cardiovascular Disease, American Board of Internal Medicine, American Board of Internal Medicine Advanced Heart Failure and Transplant Cardiology.
Dr. Kubba has extensive volunteer experience as a teacher and researcher.
In his spare time, Dr. Kubba enjoys swimming, running and calligraphy. He is fluent in English and Arabic.
Degrees
- M.D. Medical Doctor
- Weill Cornell, Doha, Qatar
Awards
- Alan T. Hirsch, MD, Travel Award
- Society Vascular Medicine, Spring 2023
Licensure & Certification
- Advanced Heart Failure & Transplant Cardiology, American Board of Internal Medicine (2022)
Interests
Teaching
Pulmonary Vascular disease,Hemodynamics,Cardiac Imaging,Cardiomyopathy and Heart Failure,Vascular Medicine
Research
Pulmonary Vascular disease,Hemodynamics,Cardiac Imaging,Cardiomyopathy and Heart Failure,Vascular Medicine
Courses
No activities entered.
Scholarly Contributions
Journals/Publications
- Insel, M., El Aini, T., Woodhead, G., Wig, R., Kubba, S., Claessen, G., Howden, E., & Rischard, F. (2024). Post-Pulmonary Embolism Phenotypes Described by Invasive Cardiopulmonary Exercise Testing. Chest.More infoPost-pulmonary embolism (PE) dyspnea is common. Existing noninvasive studies have demonstrated that post-PE dyspnea is associated with elevations in right ventricular (RV) afterload, dead space ventilation, and deconditioning. We aimed to use invasive cardiopulmonary exercise testing (iCPET) parameters in patients with post-PE dyspnea to identify unique physiologic phenotypes.
- Vanderpool, R. R., Insel, M., Kubba, S., & Rischard, F. P. (2023). The Acute Effects of Prostacyclin on Right Ventricular Contractility and Pulmonary Artery Coupling. American journal of respiratory and critical care medicine.
- Hershman, M., Singh, A., Kubba, S., Ajmal, M., & Acharya, T. (2021). Statin-Induced Triad of Autoimmune Myocarditis, Myositis, and Transaminitis.. Case reports in cardiology, 2021, 6660362. doi:10.1155/2021/6660362More infoDespite well-established cardiovascular benefits, statins have been associated with myopathic side effects ranging from myalgias to rhabdomyolysis and autoimmune necrotizing myositis. Statins have not been previously shown to cause myocarditis. Our case highlights this rare entity.
- Rischard, F., Vanderpool, R., Kubba, S., Airhart, S., Wickstrom, K., Rosado-Toro, J., & Janardhanan, R. (2018). Abstract 17250: Underestimation of RV Volume by 3D Echocardiography in Patients With Severe PAH. Circulation, 138(Suppl_1). doi:10.1161/circ.138.suppl_1.17250
Proceedings Publications
- Rischard, F., Chatterjee, A., Insel, M., Kubba, S., Habib, N., Sher, N., Tandon, A., & Seckeler, M. (2022). To Drain or Not to Drain: Hemodynamic Characterization of Tamponade in PAH. In ATS.
- Rischard, F., Kubba, S., Uhland, C., Insel, M., & Stroud, S. (2022). Oxygen Utilization as a Primary Mediator of Age-Related Functional Decline in Pulmonary Arterial Hypertension. In ATS.
- Janardhanan, R., Desai, A., Kubba, S., Airhart, S., Wickstrom, K., Rosado-Toro, J., Vanderpool, R., & Rischard, F. (2019). The Inaccuracy of Right Ventricular 3d Echocardiography Is Accentuated by Disease Severity in Pulmonary Arterial Hypertension. In ATS.
- Yuan, J., Janardhanan, R., Kubba, S., Erickson, H., Vanderpool, R., Holmathchi, J., Puri, R., Airhart, S., Lizarraga, A., Hansen, L., Naeije, R., Garcia, J., & Rischard, F. (2019). Ratio of Stroke Volume to End-Systolic Volume Predicts Change in Right Ventricular Ejection Fraction in Patients with Pulmonary Arterial Hypertension. In ATS.
Presentations
- Habib, N., Sher, A., Tandon, S., Kubba, S., Insel, M., Chatterjee, A., Seckeler, M., & Rischard, F. (2022, May). To Drain or Not to Drain: Hemodynamic Charcterization of Tamponade in Pulmonary Arterial Hypertension. American Thoracic Society 2022. San Francisco, CA.
- Kubba, S. (2022). Debate Presentation, Sodium Restriction in Heart Failure. American College of Cardiology - Arizona.
- Uhland, C., Insel, M., Stroud, S. C., Kubba, S., & Rischard, F. (2022, May). Oxygen Utilization as a Primary Mediator of Age-Related Functional Decline in Pulmonary Arterial Hypertension. American Thoracic Society 2022. San Francisco, CA.
Poster Presentations
- Ajmal, M., Kubba, S., Lee, K. S., Lerman, A., & Corban, M. (2022, November). Abstract 11774: Heart Failure with Preserved Ejection Fraction Secondary to Coronary Endothelial Dysfunction and Microvascular Disease. American Heart Association Scientific Sessions 2022. Chicago, IL.
- Badagliacca, R., Rischard, F., Papa, S., Kubba, S., Vanderpool, R., Yuan, J., Garcia, J., Airhart, S., Poscia, R., Pezzuto, B., Manzi, G., Sciomer, S., Torre, R., Fedele, F., & Vizza, C. (2019, April). Clinical Implications of Idiopathic Pulmonary Arterial Hypertension Phenotypes Defined by Cluster Analysis. International Society for Heart and Lung Transplantation 2019. Orlando, FL.
- Keeley Ravellette, K., Kubba, S., Airhart, S., Yuan, J., Rischard, F., & Vanderpool, R. (2019, April). Increased Pulmonary Vascular Impedance in Patients with Severe Pulmonary Arterial Hypertension. Experimental Biology 2019. Orlando, FL.
- Kubba, S., Airhart, S., Wickstrom, K., Rosado-Toro, J., Desai, A., Janardhanan, R., Vanderpool, R., & Rischard, F. (2019, May). The Inaccuracy of Right Ventricular 3d Echocardiography Is Accentuated by Disease Severity in Pulmonary Arterial Hypertension. American Thoracic Society 2019. Dallas, TX.
- Vanderpool, R., Holmathchi, J., Puri, R., Airhart, S., Erickson, H., Lizarraga, A., Hansen, L., Kubba, S., Janardhanan, R., Naeije, R., Garcia, J., Yuan, J., & Rischard, F. (2019, May). Ratio of Stroke Volume to End-Systolic Volume Predicts Change in Right Ventricular Ejection Fraction in Patients with Pulmonary Arterial Hypertension. American Thoracic Society 2019. Dallas, TX.
- Kubba, S., Airhart, S., Wickstrom, K., Rosado-Toro, J., Janardhanan, R., Vanderpool, R., & Rischard, F. (2018, spring). Underestimation of RV Volume by 3D Echocardiography in Patients With Severe PAH. American Heart Association Annual Scientific Session 2018. Chicago, IL.
